Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor.
Ling-Yu ChuJian-Yuan ZhouYi-Xuan ZhaoYan-Ting OuTian YangYu-Hui PengWang-Kai FangYi-Wei XuJian-Jun XiePublished in: Bioscience reports (2022)
The present study showed that CYR61 might be a potential biomarker to assist the diagnosis of EGJ tumor.
Keyphrases